Semaglutide (Ozempic) linked to fewer bone fractures despite greater weight loss

A new study suggests that semaglutide (Ozempic, Wegovy, Rybelsus) may offer an unexpected benefit for people with type 2 diabetes. Researchers found that patients taking the medication experienced fewer bone fractures and greater weight loss than those using several other anti-obesity treatments.

1. Homepage
2. Science
3. Semaglutide (Ozempic) linked to fewer bone fractures despite greater weight loss